BioSpace News Archive

Progressive Care Inc., a personalized healthcare services and technology company, issues the following Letter to Shareholders from the CEO

CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, today announced the appointment of Maura Fleming as the Company’s vice president, general counsel and corporate secretary

Legato Healthcare Marketing announces the launch of its new publication division, equipped to produce customized printed and digital magazines within and outside of the healthcare industry.

Baze, one of America’s leading evidence-based personalized nutrition companies, today announced approval from the Food and Drug Administration for its at-home blood collection process.

VisiQuate Inc. is pleased to announce that Fresenius Medical Care North America (FMCNA) has expanded a pilot program into a system-wide deployment of two of VisiQuate’s leading analytics solutions: Denials Management Analytics and Denial Flo

SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, today announced that its shares of common stock will begin trading on the Nasdaq Capital Market beginning today at 9:30 a.m., EST under the ticker symbol “SWKH.”

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today the addition of Dr. Alexander Fleming to its Scientific Advisory Board.

Today, The Committee for Economic Development of The Conference Board (CED) released A New Path on Health Care.

Cutting-edge digital pharmacy kicks off a nationwide expansion beginning with Philly location

Genome Medical, a leader in telegenomics-based clinical care, today announced that it has expanded its services to enable collaborative population genomics programs with health systems across the country.